Jay Sial - Net Worth and Insider Trading

Jay Sial Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jay Sial owns 1 companies in total, including Eterna Therapeutics Inc (ERNA) .

Click here to see the complete history of Jay Sial’s form 4 insider trades.

Insider Ownership Summary of Jay Sial

Ticker	Comapny	Transaction Date	Type of Owner
ERNA	Eterna Therapeutics Inc	2021-07-15	See Remarks

Jay Sial Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jay Sial Ownership Network

Ownership Network List of Jay Sial

No Data

Ownership Network Relation of Jay Sial

Jay Sial Owned Company Details

What does Eterna Therapeutics Inc do?

Who are the key executives at Eterna Therapeutics Inc?

Jay Sial is the See Remarks of Eterna Therapeutics Inc. Other key executives at Eterna Therapeutics Inc include 10 percent owner Charles Cherington , 10 percent owner Freebird Investments Llc , and 10 percent owner Freebird Partners Lp .

Eterna Therapeutics Inc (ERNA) Insider Trades Summary

Over the past 18 months, Jay Sial made no insider transaction in Eterna Therapeutics Inc (ERNA). Other recent insider transactions involving Eterna Therapeutics Inc (ERNA) include a net purchase of 335,920 shares made by John D Halpern , a net purchase of 283,286 shares made by Nicholas Jason Singer , and a net purchase of 261,756 shares made by Charles Cherington .

In summary, during the past 3 months, insiders sold 0 shares of Eterna Therapeutics Inc (ERNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eterna Therapeutics Inc (ERNA) were sold and 880,962 shares were bought by its insiders, resulting in a net purchase of 880,962 shares.

Eterna Therapeutics Inc (ERNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eterna Therapeutics Inc Insider Transactions

No Available Data

Jay Sial Mailing Address

Above is the net worth, insider trading, and ownership report for Jay Sial. You might contact Jay Sial via mailing address: C/o Brooklyn Immunotherapeutics, Inc., 140 58th Street, Building A, Suite 2100, Brooklyn Ny 11220.

Discussions on Jay Sial

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.